These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 16832350

  • 1. Regulation of TRAIL-induced apoptosis by XIAP in pancreatic carcinoma cells.
    Vogler M, Dürr K, Jovanovic M, Debatin KM, Fulda S.
    Oncogene; 2007 Jan 11; 26(2):248-57. PubMed ID: 16832350
    [Abstract] [Full Text] [Related]

  • 2. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
    Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Gschwend JE, Simmet T, Debatin KM, Fulda S.
    Cancer Res; 2008 Oct 01; 68(19):7956-65. PubMed ID: 18829553
    [Abstract] [Full Text] [Related]

  • 3. Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.
    Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Bhanot U, Hasel C, Möller P, Gschwend JE, Simmet T, Debatin KM, Fulda S.
    Cancer Res; 2009 Mar 15; 69(6):2425-34. PubMed ID: 19258513
    [Abstract] [Full Text] [Related]

  • 4. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.
    Mori T, Doi R, Kida A, Nagai K, Kami K, Ito D, Toyoda E, Kawaguchi Y, Uemoto S.
    J Surg Res; 2007 Oct 15; 142(2):281-6. PubMed ID: 17640673
    [Abstract] [Full Text] [Related]

  • 5. Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.
    Yano K, Horinaka M, Yoshida T, Yasuda T, Taniguchi H, Goda AE, Wakada M, Yoshikawa S, Nakamura T, Kawauchi A, Miki T, Sakai T.
    Int J Oncol; 2011 Feb 15; 38(2):365-74. PubMed ID: 21165560
    [Abstract] [Full Text] [Related]

  • 6. Sensitization of pancreatic carcinoma cells for gamma-irradiation-induced apoptosis by XIAP inhibition.
    Giagkousiklidis S, Vellanki SH, Debatin KM, Fulda S.
    Oncogene; 2007 Oct 25; 26(49):7006-16. PubMed ID: 17471230
    [Abstract] [Full Text] [Related]

  • 7. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells.
    Shi RX, Ong CN, Shen HM.
    Cancer Res; 2005 Sep 01; 65(17):7815-23. PubMed ID: 16140950
    [Abstract] [Full Text] [Related]

  • 8. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma.
    Ndozangue-Touriguine O, Sebbagh M, Mérino D, Micheau O, Bertoglio J, Bréard J.
    Oncogene; 2008 Oct 09; 27(46):6012-22. PubMed ID: 18560353
    [Abstract] [Full Text] [Related]

  • 9. MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release.
    Mohr A, Büneker C, Gough RP, Zwacka RM.
    Oncogene; 2008 Jan 31; 27(6):763-74. PubMed ID: 17653087
    [Abstract] [Full Text] [Related]

  • 10. Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells.
    Mohr A, Albarenque SM, Deedigan L, Yu R, Reidy M, Fulda S, Zwacka RM.
    Stem Cells; 2010 Nov 31; 28(11):2109-20. PubMed ID: 20882532
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.
    Fulda S, Meyer E, Debatin KM.
    Oncogene; 2002 Apr 04; 21(15):2283-94. PubMed ID: 11948412
    [Abstract] [Full Text] [Related]

  • 12. IFN-γ combined with targeting of XIAP leads to increased apoptosis-sensitisation of TRAIL resistant pancreatic carcinoma cells.
    Büneker CK, Yu R, Deedigan L, Mohr A, Zwacka RM.
    Cancer Lett; 2012 Mar 28; 316(2):168-77. PubMed ID: 22104728
    [Abstract] [Full Text] [Related]

  • 13. Smac/DIABLO release from mitochondria and XIAP inhibition are essential to limit clonogenicity of Type I tumor cells after TRAIL receptor stimulation.
    Maas C, Verbrugge I, de Vries E, Savich G, van de Kooij LW, Tait SW, Borst J.
    Cell Death Differ; 2010 Oct 28; 17(10):1613-23. PubMed ID: 20395960
    [Abstract] [Full Text] [Related]

  • 14. Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells.
    Lippa MS, Strockbine LD, Le TT, Branstetter DG, Strathdee CA, Holland PM.
    Apoptosis; 2007 Aug 28; 12(8):1465-78. PubMed ID: 17440816
    [Abstract] [Full Text] [Related]

  • 15. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
    Yamaguchi Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, Saitou Y, Sugimoto K, Nakano T.
    Oncol Rep; 2005 Nov 28; 14(5):1311-6. PubMed ID: 16211302
    [Abstract] [Full Text] [Related]

  • 16. Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis.
    Hörnle M, Peters N, Thayaparasingham B, Vörsmann H, Kashkar H, Kulms D.
    Oncogene; 2011 Feb 03; 30(5):575-87. PubMed ID: 20856198
    [Abstract] [Full Text] [Related]

  • 17. Synergistic antitumor activity of XIAP-shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC.
    Pan Q, Liu B, Liu J, Cai R, Liu X, Qian C.
    Acta Oncol; 2008 Feb 03; 47(1):135-44. PubMed ID: 17934893
    [Abstract] [Full Text] [Related]

  • 18. Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells.
    Braeuer SJ, Büneker C, Mohr A, Zwacka RM.
    Mol Cancer Res; 2006 Oct 03; 4(10):715-28. PubMed ID: 17050666
    [Abstract] [Full Text] [Related]

  • 19. A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia.
    Loeder S, Zenz T, Schnaiter A, Mertens D, Winkler D, Döhner H, Debatin KM, Stilgenbauer S, Fulda S.
    Cancer Res; 2009 Dec 01; 69(23):8977-86. PubMed ID: 19920200
    [Abstract] [Full Text] [Related]

  • 20. Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic beta cells by Bcl-2 and X-linked inhibitor of apoptosis.
    Ou D, Wang X, Metzger DL, James RF, Pozzilli P, Plesner A, Korneluk RG, Verchere CB, Tingle AJ.
    Hum Immunol; 2005 Mar 01; 66(3):274-84. PubMed ID: 15784465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.